The chemical class known as Plakophilin 1 Activators encompasses a range of compounds that, while not directly activating Plakophilin 1, engage with various cellular pathways and processes that are closely related to the functions of this protein. Plakophilin 1, integral to cell-cell adhesion and involved in desmosomal structure and function, plays a pivotal role in maintaining cellular integrity, particularly in tissues that require mechanical resilience. The compounds listed in this class act on various signaling pathways, such as kinase signaling, PI3K/Akt pathways, MAPK pathways, and EGFR signaling, which are known to be crucial in regulating cell adhesion, integrity, and communication. For instance, inhibitors like Staurosporine and Bisindolylmaleimide I, which target protein kinases broadly, could impact the signaling cascades that govern the functionality of Plakophilin 1, indirectly modulating its activity in the cell. Similarly, PI3K inhibitors such as LY294002 and Wortmannin, by altering the PI3K/Akt pathway, might affect the signaling milieu in which Plakophilin 1 operates, potentially influencing its role in cell adhesion processes.
Furthermore, compounds like U0126 and PD98059, which are MEK inhibitors, along with SB203580, a p38 MAPK inhibitor, could have a significant impact on the MAPK/ERK signaling pathways. These pathways are integral to numerous cellular processes, including those that govern cell adhesion and integrity, areas where Plakophilin 1 is critically involved. The alteration of these pathways by these inhibitors might, therefore, have an indirect effect on the activity of Plakophilin 1. Additionally, mTOR inhibitor Rapamycin and JNK inhibitor SP600125 represent further examples of how modulation of key signaling nodes can indirectly affect proteins involved in cell adhesion, including Plakophilin 1. EGFR inhibitors like Gefitinib and Erlotinib, known for their roles in modulating cell growth and adhesion signaling, also potentially impact Plakophilin 1's activity in the broader context of cell-cell adhesion and integrity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A protein kinase C inhibitor that could influence cell adhesion pathways associated with Plakophilin 1. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Another PKC inhibitor, might impact Plakophilin 1 activity by altering cellular adhesion signaling pathways. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR inhibitor, might affect cell adhesion and signaling pathways related to Plakophilin 1. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Another EGFR inhibitor, could influence signaling pathways impacting Plakophilin 1's functions in cell adhesion. | ||||||